查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1980620

介入性心臟病醫療設備市場：規模、佔有率、成長率和全球產業分析（按類型和應用）、區域洞察以及2026-2034年預測

Interventional Cardiology Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 163 Pages | 商品交期: 請詢問到貨日

價格

介入性心臟病設備市場的成長要素

全球介入性心臟病設備市場預計到 2025 年將達到 178.6 億美元，從 2026 年的 191.2 億美元成長到 2034 年的 340.1 億美元，2026 年至 2034 年的複合年成長率為 7.50%。北美在 2025 年佔全球市場的主導地位，市場佔有率為 33.90%，這主要得益於冠狀動脈疾病發病率的上升、有利的報銷方案以及持續的產品創新。

介入性心臟病學器械是用於微創手術治療冠狀動脈疾病（CAD）、結構性心臟疾病和其他心血管疾病的專用儀器。冠狀動脈支架、血管成形術用氣球、切割球囊導管和經皮冠狀動脈成形術（PTCA）系統等器械在醫院和心臟導管檢查室中廣泛使用。

根據世界衛生組織（世衛組織）的數據，心血管疾病是全球首要死因，每年約造成1,790萬人死亡。此外，美國疾病管制與預防中心（CDC）報告稱，2020年約有2010萬美國成年人患有冠狀動脈疾病。日益加重的疾病負擔持續推動對先進介入性心臟病學設備的需求。

新冠疫情的影響

2020年，新冠疫情導致擇期心血管手術延期，對市場造成了負面影響。醫院優先治療新冠患者，導致冠狀動脈疾病和結構性心臟疾病的治療延誤。然而，2021年，全球範圍內擇期手術和介入治療逐漸恢復，市場顯著復甦。疫情後，由於微創介入治療住院時間短、恢復快、感染控制措施更嚴格，醫療專業人員越來越傾向於選擇此類治療，這為市場的長期成長提供了支撐。

市場趨勢

向微創手術的轉變

微創心臟治療越來越受歡迎，這是主要趨勢之一。這些治療方法併發症更少、住院時間更短、切口更小，患者康復速度更快。

根據美國心臟協會統計，全球每年約進行150萬例心血管手術。光是在美國，每年就約進行90萬例經皮冠狀動脈介入治療（PCI）。

保險覆蓋範圍的擴大進一步加速了這些手術的普及。 2020年，美國醫療保險和醫療補助服務中心（CMS）宣布，在門診手術中心（ASC）和門診檢查室（OBL）進行的經皮冠狀動脈介入治療（PCI）手術將納入保險覆蓋範圍，從而增加了在非醫院機構進行的手術數量。

市場成長要素

心血管疾病負擔加重

污染、吸煙、飲酒、久坐不動的生活方式和不健康的飲食等環境風險因素的增加，正在導致全球心血管疾病發病率的上升。根據美國心臟學會（ACC）統計，亞洲心血管疾病相關死亡人數從1990年的560萬增加到2019年的1080萬人。

產品發布及策略合作

主要企業正積極投資研發，並將創新醫療設備推向市場，以滿足日益成長的市場需求。例如，2021年7月，Medtronic在歐洲推出了用於經皮冠狀動脈介入治療（PCI）的Prevail藥物釋放型球囊（DCB）導管。同樣，各公司也積極尋求合作、收購和監管核准，以增強產品系列。

抑制因子

儘管成長前景強勁，但產品召回和監管仍然是挑戰。 2023年7月，雅培公司宣布召回用於左心耳封堵術的心臟導管，原因是安全隱患。此外，血腫、血管損傷和橈動脈閉塞等併發症可能會阻礙此類器械的廣泛應用。嚴格的監管核准流程也會延緩新產品的上市。

細分分析

副產品

市場區隔包括冠狀動脈支架、結構性心臟疾病器械、血管成形術用氣球、栓塞預防器械等。

  • 預計到 2025 年，冠狀動脈支架將佔市場主導地位，市場佔有率達到 38.55%，這主要得益於中國等國家較高的手術量以及政府主導的採購計劃。
  • 由於經導管主動脈瓣置換術)的數量不斷增加，預計結構性心臟裝置的年複合成長率將會更高。
  • 預計用於血管生成的球囊領域也將迎來顯著成長。

最終用戶

  • 到 2026 年，醫院和門診手術中心 (ASC) 將佔市場佔有率的 66.21%，這主要得益於住院患者數量和手術量的增加。
  • 隨著全球基礎設施的擴張，導管介入檢查室及相關領域預計將經歷適度成長。

區域趨勢

北美洲

預計到2025年，北美市場規模將達到60.5億美元，其持續成長的動力來自於優惠的還款方案和技術進步。美國市場預計到2026年將達到61.8億美元。

歐洲

歐洲佔了相當大的市場佔有率，這主要得益於價格適中的醫療設備和不斷增加的監管核准。預計到2026年，英國市場規模將達到6.8億美元，德國市場規模預計將達到15.2億美元。

亞太地區

受患者人數成長和國內製造業發展推動，亞太地區預計在2025年至2034年間實現最高的複合年成長率。預計2026年，中國市場規模將達9.8億美元，日本4.7億美元，印度7.9億美元。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 2023/2025年主要國家/地區心血管疾病盛行率
  • 2023/2025年主要國家/地區心房顫動發生率
  • 流行病學：主要國家/地區2023/2025年卒中狀況
  • 2023/2025年主要國家經皮皮冠狀動脈介入治療（PCI）數量
  • 新產品發布：按主要企業分類
  • 產業重大發展動態－併購與合作
  • 新冠疫情對市場的影響

第5章：2021-2034年全球介入性心臟病醫療設備市場分析、洞察與預測

  • 市場分析、洞察與預測：按產品分類。
    • 冠狀動脈支架
      • 裸金屬支架（BMS）
      • 藥物釋放型支架（DES）
      • 其他
    • 結構性心臟疾病治療裝置
      • 心臟瓣膜
      • 閉塞裝置及其他
    • 用於血管生成的球囊
    • 導管
      • 診斷導管
      • 治療性導管
    • 栓塞預防裝置
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 醫院及日間手術中心
    • 導管檢查室及其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美介入性心臟病醫療設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲介入性心臟病醫療設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 英國
    • 其他歐洲國家

第8章：亞太地區介入性心臟病醫療設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲介入性心臟病醫療設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • 墨西哥
    • 巴西
    • 其他拉丁美洲國家

第10章：中東和非洲介入性心臟病醫療設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • Boston Scientific Corporation
    • Abbott
    • Medtronic
    • BIOTRONIK SE & Co. KG
    • iVascular
    • Terumo Corporation
    • Teleflex Incorporated
    • B. Braun SE
    • Alvimedica
    • Biosensors International Group, Ltd
Product Code: FBI107414

Growth Factors of interventional cardiology devices Market

The global interventional cardiology devices market was valued at USD 17.86 billion in 2025 and is projected to grow from USD 19.12 billion in 2026 to USD 34.01 billion by 2034, registering a CAGR of 7.50% during 2026-2034. North America dominated the global market with a 33.90% share in 2025, driven by the rising incidence of coronary heart diseases, favorable reimbursement frameworks, and continuous product innovations.

Interventional cardiology devices are specialized tools used in minimally invasive procedures to treat coronary artery disease (CAD), structural heart disorders, and other cardiovascular conditions. Devices such as coronary stents, angioplasty balloons, cutting balloon catheters, and Percutaneous Transluminal Coronary Angioplasty (PTCA) systems are widely used across hospitals and cardiac catheterization laboratories.

According to the World Health Organization, cardiovascular diseases (CVDs) account for approximately 17.9 million deaths globally each year, making them the leading cause of mortality worldwide. Additionally, the Centers for Disease Control and Prevention reported that around 20.1 million U.S. adults suffered from coronary artery disease in 2020. This increasing disease burden continues to fuel demand for advanced interventional cardiology devices.

COVID-19 Impact

The COVID-19 pandemic negatively impacted the market in 2020 due to postponement of elective cardiac procedures. Hospitals prioritized COVID-19 cases, delaying coronary and structural heart treatments. However, substantial recovery was observed in 2021 as elective and interventional procedures resumed globally. Post-pandemic, healthcare professionals increasingly prefer minimally invasive interventional procedures due to shorter hospital stays, faster recovery, and better infection control, supporting long-term market expansion.

Market Trends

Shifting Preference Toward Minimally Invasive Procedures

The growing preference for minimally invasive cardiac procedures is a key trend. These procedures offer reduced complications, shorter hospital stays, minimal incisions, and faster patient recovery.

According to the American Heart Association, approximately 1.5 million cardiac surgeries are performed globally each year. In the U.S. alone, nearly 900,000 Percutaneous Coronary Interventions (PCIs) are performed annually.

Reimbursement expansion has further strengthened adoption. In 2020, the Centers for Medicare & Medicaid Services announced reimbursement coverage for PCI procedures in Ambulatory Surgical Centers (ASCs) and Office-Based Labs (OBLs), accelerating procedural volumes outside hospital settings.

Market Growth Drivers

Rising Cardiovascular Disease Burden

Increasing environmental risk factors such as pollution, smoking, alcohol consumption, sedentary lifestyles, and unhealthy diets are contributing to the global rise in cardiovascular diseases. According to the American College of Cardiology, cardiovascular-related deaths in Asia increased from 5.6 million in 1990 to 10.8 million in 2019.

Product Launches and Strategic Collaborations

Major players are actively investing in R&D and launching innovative devices to meet growing demand. For instance, in July 2021, Medtronic launched the Prevail Drug-Coated Balloon (DCB) catheter in Europe for PCI procedures. Similarly, companies are engaging in partnerships, acquisitions, and regulatory approvals to strengthen product portfolios across emerging economies such as China and India.

Restraining Factors

Despite strong growth prospects, product recalls and regulatory scrutiny pose challenges. In July 2023, Abbott issued a recall for a cardiac catheter used in left atrial appendage occlusion due to safety concerns. Additionally, complications such as hematoma, vascular injury, and radial artery occlusion may limit device adoption. Strict regulatory approval processes also slow new product commercialization.

Segmentation Analysis

By Product

The market is segmented into coronary stents, structural heart devices, angioplasty balloons, catheters, embolic protection devices, and others.

  • Coronary stents dominated the market with a 38.55% share in 2025, driven by high procedural volumes and government-led procurement programs in countries like China.
  • Structural heart devices are projected to grow at a higher CAGR due to rising Transcatheter Aortic Valve Replacement (TAVR) procedures.
  • Angioplasty balloons are also expected to witness substantial growth.

By End User

  • Hospitals & Ambulatory Surgical Centers (ASCs) accounted for 66.21% share in 2026, owing to rising hospital admissions and procedure volumes.
  • Catheterization labs & others are projected to grow moderately with expanding infrastructure globally.

Regional Insights

North America

North America generated USD 6.05 billion in 2025 and continues to dominate due to strong reimbursement policies and technological advancements. The U.S. market is projected to reach USD 6.18 billion by 2026.

Europe

Europe holds a significant share driven by affordable device pricing and rising regulatory approvals. The UK market is projected to reach USD 0.68 billion by 2026, while Germany is expected to reach USD 1.52 billion by 2026.

Asia Pacific

Asia Pacific is projected to register the highest CAGR during 2025-2034 due to expanding patient pools and domestic manufacturing growth. China is projected to reach USD 0.98 billion by 2026, Japan USD 0.47 billion, and India USD 0.79 billion.

Competitive Landscape

Prominent companies operating in the market include Edwards Lifesciences, Boston Scientific Corporation, Abbott, Medtronic, BIOTRONIK SE & Co. KG, Terumo Corporation, and B. Braun SE. These companies are focusing on product innovation, acquisitions, regulatory approvals, and geographic expansion to strengthen their global footprint.

Conclusion

The global interventional cardiology devices market is set for robust growth from USD 17.86 billion in 2025 to USD 34.01 billion by 2034, supported by the rising burden of cardiovascular diseases, increasing preference for minimally invasive procedures, expanding reimbursement coverage, and continuous technological advancements. While product recalls and regulatory challenges may restrain short-term growth, sustained innovation, strategic partnerships, and expanding healthcare infrastructure-especially in Asia Pacific-will ensure strong long-term market expansion through 2034.

Unit CAGR of 7.50% from 2026-2034

Segmentation By Product

  • Coronary Stents
    • Bare-metal Stent (BMS)
    • Drug-eluting Stent (DES)
    • Others
  • Structural Heart Devices
    • Heart Valves
    • Occluders & Others
  • Angioplasty Balloons
  • Catheters
    • Diagnostic Catheters
  • Angiography
  • IVUS
  • Others
    • Treatment Catheters
  • Atherectomy
  • Thrombectomy
  • Ablation
  • Others
  • Embolic Protection Devices
  • Others

By End User

  • Hospitals & ASCs
  • Catheterization Labs & Others

By Region

  • North America (By Product, End User, and Country)
    • U.S.
    • Canada
  • Europe (By Product, End User, and Country/Sub-region)
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Product, End User, and Country/Sub-region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, End User, and Country/Sub-region)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (By Product, End User, and Country/Sub-region)
    • GCC
    • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Cardiovascular Diseases, By Key Countries/ Region, 2023/2025
  • 4.2. Incidence of Atrial Fibrillation, By Key Countries/ Region, 2023/2025
  • 4.3. Epidemiology: Stroke, By Key Countries/ Region, 2023/2025
  • 4.4. Number of Percutaneous Coronary Interventions Procedures, By Key Countries, 2023/2025
  • 4.5. New Product Launches, By Key Players
  • 4.6. Key Industry Developments - Mergers, Acquisition, and Partnerships
  • 4.7. Impact of COVID-19 on the Market

5. Global Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Coronary Stents
      • 5.1.1.1. Bare-metal Stent (BMS)
      • 5.1.1.2. Drug-eluting Stent (DES)
      • 5.1.1.3. Others
    • 5.1.2. Structural Heart Devices
      • 5.1.2.1. Heart Valves
      • 5.1.2.2. Occluders & Others
    • 5.1.3. Angioplasty Balloons
    • 5.1.4. Catheters
      • 5.1.4.1. Diagnostic Catheters
        • 5.1.4.1.1. Angiography
        • 5.1.4.1.2. IVUS
        • 5.1.4.1.3. Others
      • 5.1.4.2. Treatment Catheters
        • 5.1.4.2.1. Atherectomy
        • 5.1.4.2.2. Thrombectomy
        • 5.1.4.2.3. Ablation
        • 5.1.4.2.4. Others
    • 5.1.5. Embolic Protection Devices
    • 5.1.6. Others
  • 5.2. Market Analysis, Insights and Forecast - By End User
    • 5.2.1. Hospitals & ASCs
    • 5.2.2. Catheterization Labs & Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East and Africa

6. North America Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Coronary Stents
      • 6.1.1.1. Bare-metal Stent (BMS)
      • 6.1.1.2. Drug-eluting Stent (DES)
      • 6.1.1.3. Others
    • 6.1.2. Structural Heart Devices
      • 6.1.2.1. Heart Valves
      • 6.1.2.2. Occluders & Others
    • 6.1.3. Angioplasty Balloons
    • 6.1.4. Catheters
      • 6.1.4.1. Diagnostic Catheters
        • 6.1.4.1.1. Angiography
        • 6.1.4.1.2. IVUS
        • 6.1.4.1.3. Others
      • 6.1.4.2. Treatment Catheters
        • 6.1.4.2.1. Atherectomy
        • 6.1.4.2.2. Thrombectomy
        • 6.1.4.2.3. Ablation
        • 6.1.4.2.4. Others
    • 6.1.5. Embolic Protection Devices
    • 6.1.6. Others
  • 6.2. Market Analysis, Insights and Forecast - By End User
    • 6.2.1. Hospitals & ASCs
    • 6.2.2. Catheterization Labs & Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Coronary Stents
      • 7.1.1.1. Bare-metal Stent (BMS)
      • 7.1.1.2. Drug-eluting Stent (DES)
      • 7.1.1.3. Others
    • 7.1.2. Structural Heart Devices
      • 7.1.2.1. Heart Valves
      • 7.1.2.2. Occluders & Others
    • 7.1.3. Angioplasty Balloons
    • 7.1.4. Catheters
      • 7.1.4.1. Diagnostic Catheters
        • 7.1.4.1.1. Angiography
        • 7.1.4.1.2. IVUS
        • 7.1.4.1.3. Others
      • 7.1.4.2. Treatment Catheters
        • 7.1.4.2.1. Atherectomy
        • 7.1.4.2.2. Thrombectomy
        • 7.1.4.2.3. Ablation
        • 7.1.4.2.4. Others
    • 7.1.5. Embolic Protection Devices
    • 7.1.6. Others
  • 7.2. Market Analysis, Insights and Forecast - By End User
    • 7.2.1. Hospitals & ASCs
    • 7.2.2. Catheterization Labs & Others
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.3.1. Germany
    • 7.3.2. Spain
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. U.K.
    • 7.3.6. Rest of Europe

8. Asia Pacific Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Coronary Stents
      • 8.1.1.1. Bare-metal Stent (BMS)
      • 8.1.1.2. Drug-eluting Stent (DES)
      • 8.1.1.3. Others
    • 8.1.2. Structural Heart Devices
      • 8.1.2.1. Heart Valves
      • 8.1.2.2. Occluders & Others
    • 8.1.3. Angioplasty Balloons
    • 8.1.4. Catheters
      • 8.1.4.1. Diagnostic Catheters
        • 8.1.4.1.1. Angiography
        • 8.1.4.1.2. IVUS
        • 8.1.4.1.3. Others
      • 8.1.4.2. Treatment Catheters
        • 8.1.4.2.1. Atherectomy
        • 8.1.4.2.2. Thrombectomy
        • 8.1.4.2.3. Ablation
        • 8.1.4.2.4. Others
    • 8.1.5. Embolic Protection Devices
    • 8.1.6. Others
  • 8.2. Market Analysis, Insights and Forecast - By End User
    • 8.2.1. Hospitals & ASCs
    • 8.2.2. Catheterization Labs & Others
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. China
    • 8.3.2. India
    • 8.3.3. Japan
    • 8.3.4. Australia
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific

9. Latin America Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Coronary Stents
      • 9.1.1.1. Bare-metal Stent (BMS)
      • 9.1.1.2. Drug-eluting Stent (DES)
      • 9.1.1.3. Others
    • 9.1.2. Structural Heart Devices
      • 9.1.2.1. Heart Valves
      • 9.1.2.2. Occluders & Others
    • 9.1.3. Angioplasty Balloons
    • 9.1.4. Catheters
      • 9.1.4.1. Diagnostic Catheters
        • 9.1.4.1.1. Angiography
        • 9.1.4.1.2. IVUS
        • 9.1.4.1.3. Others
      • 9.1.4.2. Treatment Catheters
        • 9.1.4.2.1. Atherectomy
        • 9.1.4.2.2. Thrombectomy
        • 9.1.4.2.3. Ablation
        • 9.1.4.2.4. Others
    • 9.1.5. Embolic Protection Devices
    • 9.1.6. Others
  • 9.2. Market Analysis, Insights and Forecast - By End User
    • 9.2.1. Hospitals & ASCs
    • 9.2.2. Catheterization Labs & Others
  • 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.3.1. Mexico
    • 9.3.2. Brazil
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Coronary Stents
      • 10.1.1.1. Bare-metal Stent (BMS)
      • 10.1.1.2. Drug-eluting Stent (DES)
      • 10.1.1.3. Others
    • 10.1.2. Structural Heart Devices
      • 10.1.2.1. Heart Valves
      • 10.1.2.2. Occluders & Others
    • 10.1.3. Angioplasty Balloons
    • 10.1.4. Catheters
      • 10.1.4.1. Diagnostic Catheters
        • 10.1.4.1.1. Angiography
        • 10.1.4.1.2. IVUS
        • 10.1.4.1.3. Others
      • 10.1.4.2. Treatment Catheters
        • 10.1.4.2.1. Atherectomy
        • 10.1.4.2.2. Thrombectomy
        • 10.1.4.2.3. Ablation
        • 10.1.4.2.4. Others
    • 10.1.5. Embolic Protection Devices
    • 10.1.6. Others
  • 10.2. Market Analysis, Insights and Forecast - By End User
    • 10.2.1. Hospitals & ASCs
    • 10.2.2. Catheterization Labs & Others
  • 10.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.3.1. GCC
    • 10.3.2. South Africa
    • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Boston Scientific Corporation
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Abbott
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Medtronic
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. BIOTRONIK SE & Co. KG
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. iVascular
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Terumo Corporation
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Teleflex Incorporated
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. B. Braun SE
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Alvimedica
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Biosensors International Group, Ltd
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 02: Global Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Coronary Stents, 2021-2034
  • Table 03: Global Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Structural Heart Devices, 2021-2034
  • Table 04: Global Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Catheters, 2021-2034
  • Table 05: Global Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Diagnostic Catheters, 2021-2034
  • Table 06: Global Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Treatment Catheters, 2021-2034
  • Table 07: Global Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 08: Global Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 09: North America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 10: North America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Coronary Stents, 2021-2034
  • Table 11: North America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Structural Heart Devices, 2021-2034
  • Table 12: North America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Catheters, 2021-2034
  • Table 13: North America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Diagnostic Catheters, 2021-2034
  • Table 14: North America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Treatment Catheters, 2021-2034
  • Table 15: North America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 16: North America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 17: Europe Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 18: Europe Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Coronary Stents, 2021-2034
  • Table 19: Europe Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Structural Heart Devices, 2021-2034
  • Table 20: Europe Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Catheters, 2021-2034
  • Table 21: Europe Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Diagnostic Catheters, 2021-2034
  • Table 22: Europe Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Treatment Catheters, 2021-2034
  • Table 23: Europe Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 24: Europe Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Asia Pacific Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 26: Asia Pacific Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Coronary Stents, 2021-2034
  • Table 27: Asia Pacific Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Structural Heart Devices, 2021-2034
  • Table 28: Asia Pacific Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Catheters, 2021-2034
  • Table 29: Asia Pacific Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Diagnostic Catheters, 2021-2034
  • Table 30: Asia Pacific Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Treatment Catheters, 2021-2034
  • Table 31: Asia Pacific Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 32: Asia Pacific Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 33: Latin America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 34: Latin America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Coronary Stents, 2021-2034
  • Table 35: Latin America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Structural Heart Devices, 2021-2034
  • Table 36: Latin America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Catheters, 2021-2034
  • Table 37: Latin America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Diagnostic Catheters, 2021-2034
  • Table 38: Latin America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Treatment Catheters, 2021-2034
  • Table 39: Latin America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 40: Latin America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 41: Middle East & Africa Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 42: Middle East & Africa Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Coronary Stents, 2021-2034
  • Table 43: Middle East & Africa Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Structural Heart Devices, 2021-2034
  • Table 44: Middle East & Africa Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Catheters, 2021-2034
  • Table 45: Middle East & Africa Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Diagnostic Catheters, 2021-2034
  • Table 46: Middle East & Africa Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Treatment Catheters, 2021-2034
  • Table 47: Middle East & Africa Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 48: Middle East & Africa Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 01: Global Interventional Cardiology Devices Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 02: Global Interventional Cardiology Devices Market Value Share (%), By Product, 2025 & 2034
  • Figure 03: Global Interventional Cardiology Devices Market Value Share (%), By End User, 2025 & 2034
  • Figure 04: Global Interventional Cardiology Devices Market Value Share (%), By Region, 2025 & 2034
  • Figure 05: North America Interventional Cardiology Devices Market Value (USD billion), by Product, 2025 & 2034
  • Figure 06: North America Interventional Cardiology Devices Market Value Share (%), by Product, 2025
  • Figure 07: North America Interventional Cardiology Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 08: North America Interventional Cardiology Devices Market Value Share (%), by End User, 2025
  • Figure 09: North America Interventional Cardiology Devices Market Value (USD billion), by Country, 2025 & 2034
  • Figure 10: North America Interventional Cardiology Devices Market Value Share (%), by Country, 2025
  • Figure 11: Europe Interventional Cardiology Devices Market Value (USD billion), by Product, 2025 & 2034
  • Figure 12: Europe Interventional Cardiology Devices Market Value Share (%), by Product, 2025
  • Figure 13: Europe Interventional Cardiology Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 14: Europe Interventional Cardiology Devices Market Value Share (%), by End User, 2025
  • Figure 15: Europe Interventional Cardiology Devices Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Interventional Cardiology Devices Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Interventional Cardiology Devices Market Value (USD billion), by Product, 2025 & 2034
  • Figure 18: Asia Pacific Interventional Cardiology Devices Market Value Share (%), by Product, 2025
  • Figure 19: Asia Pacific Interventional Cardiology Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 20: Asia Pacific Interventional Cardiology Devices Market Value Share (%), by End User, 2025
  • Figure 21: Asia Pacific Interventional Cardiology Devices Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Interventional Cardiology Devices Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 23: Latin America Interventional Cardiology Devices Market Value (USD billion), by Product, 2025 & 2034
  • Figure 24: Latin America Interventional Cardiology Devices Market Value Share (%), by Product, 2025
  • Figure 25: Latin America Interventional Cardiology Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 26: Latin America Interventional Cardiology Devices Market Value Share (%), by End User, 2025
  • Figure 27: Latin America Interventional Cardiology Devices Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Interventional Cardiology Devices Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 29: Middle East & Africa Interventional Cardiology Devices Market Value (USD billion), by Product, 2025 & 2034
  • Figure 30: Middle East & Africa Interventional Cardiology Devices Market Value Share (%), by Product, 2025
  • Figure 31: Middle East & Africa Interventional Cardiology Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 32: Middle East & Africa Interventional Cardiology Devices Market Value Share (%), by End User, 2025
  • Figure 33: Middle East & Africa Interventional Cardiology Devices Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East & Africa Interventional Cardiology Devices Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 35: Global Interventional Cardiology Devices Market Share (%), By Company, 2025